Management of Aphthous Ulcers
Begin with topical corticosteroids as first-line therapy for all aphthous ulcers, selecting the formulation based on ulcer location and extent, and escalate to systemic therapy only for refractory or severe recurrent cases. 1, 2, 3
First-Line Topical Therapy
Topical Corticosteroids (Primary Treatment)
For localized, accessible ulcers:
- Apply clobetasol 0.05% gel or ointment directly to dried ulcer 2-4 times daily 1, 2, 3
- Alternatively, use triamcinolone acetonide 0.1% paste applied to dried ulcer 2-4 times daily 1
For multiple or widespread ulcers:
- Use betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water as rinse-and-spit solution 4 times daily 1, 2, 3
- Alternatively, dexamethasone mouth rinse (0.1 mg/mL) can be used 1, 3
Pain Management (Essential Adjunct)
- Apply viscous lidocaine 2% topically 3-4 times daily, particularly before meals 1, 2, 3
- Use benzydamine hydrochloride rinse or spray every 3 hours, especially before eating 1, 2
- Consider amlexanox 5% oral paste (topical NSAID) for severe pain 1
Barrier Protection and Oral Hygiene
- Apply mucoprotectant mouthwashes (Gelclair or Gengigel) 3 times daily to protect ulcerated mucosa 1, 2, 3
- Rinse with warm saline mouthwashes daily to reduce bacterial colonization 1, 2
- Use 0.2% chlorhexidine digluconate mouthwash twice daily as antiseptic rinse 1, 2, 3
- Important caveat: Chlorhexidine can paradoxically cause aphthous ulcers in rare cases and may cause tooth staining 4
Supportive Measures
- Apply white soft paraffin ointment to lips every 2 hours if lip involvement present 1
- Avoid crunchy, spicy, acidic foods and hot beverages 5, 1
- Discontinue toothpastes containing sodium lauryl sulfate 6
- Avoid alcohol and carbonated drinks 6
Second-Line Therapy for Refractory Cases
When topical therapy fails after 1-2 weeks:
Intralesional Steroids
- Inject triamcinolone weekly (total dose up to 28 mg) for persistent localized ulcers 1, 2, 3
- Can be combined with topical clobetasol for enhanced effect 2
Alternative Topical Agents
Systemic Therapy for Severe or Recurrent Cases
For recurrent aphthous stomatitis (≥4 episodes per year) or highly symptomatic cases:
First-Line Systemic Agent
- Colchicine is the preferred first-line systemic therapy, particularly effective when erythema nodosum or genital ulcers are also present 1, 2, 3, 7
Systemic Corticosteroids (For Severe Cases)
- Prednisone/prednisolone 30-60 mg (or 1 mg/kg) for 1 week, then taper over the second week 5, 1, 2, 3
- Critical pitfall: Do not taper corticosteroids prematurely before disease control is established 1
Third-Line Immunosuppressive Agents (Resistant Cases)
- Consider azathioprine, interferon-alpha, TNF-alpha inhibitors, or apremilast for cases resistant to colchicine and corticosteroids 5, 1, 2, 3
- Thalidomide is highly effective but reserved as last resort due to toxicity profile 8, 7, 9
When to Refer or Investigate Further
Refer to specialist if:
- Ulcers persist >2 weeks despite treatment 1, 3
- No response after 1-2 weeks of appropriate therapy 1
- Biopsy is mandatory for ulcers lasting >2 weeks to rule out malignancy 1, 3
Investigate for underlying systemic conditions:
- Obtain complete blood count, nutritional studies (iron, folate, B12), celiac serology, and HIV testing if recurrent 1, 7, 10
- Consider inflammatory bowel disease, Behçet's disease, or immunodeficiency in recurrent cases 7, 10, 6
Treatment Algorithm Summary
- Start with topical corticosteroids (clobetasol for localized, betamethasone rinse for widespread) + pain control (lidocaine, benzydamine) + barrier agents 1, 2, 3
- Add oral hygiene measures (saline rinses, chlorhexidine) and dietary modifications 1, 2
- If no improvement in 1-2 weeks: Add intralesional triamcinolone or tacrolimus ointment 1, 2
- For recurrent cases (≥4/year): Start colchicine as systemic therapy 1, 2, 3
- For severe refractory cases: Short course of systemic corticosteroids with proper taper 5, 1, 2
- For resistant cases: Consider immunosuppressive agents (azathioprine, biologics) 1, 2, 3
Key pitfall to avoid: The evidence from diabetic foot ulcer management 5 is not applicable to oral aphthous ulcers and should be disregarded in this context.